TY - JOUR
T1 - Cluster analysis of cardiovascular and metabolic risk factors in women of reproductive age
AU - Tzeng, Chii Ruey
AU - Chang, Yuan Chin Ivan
AU - Chang, Yu Chia
AU - Wang, Chia-Woei
AU - Chen, Chi Huang
AU - Hsu, Ming I.
PY - 2014/5
Y1 - 2014/5
N2 - Objective To study the association between endocrine disturbances and metabolic complications in women seeking gynecologic care. Design Retrospective study, cluster analysis. Setting Outpatient clinic, university medical center. Patient(s) 573 women, including 384 at low risk and 189 at high risk of cardiometabolic disease. Intervention(s) None. Main Outcome Measure(s) Cardiovascular and metabolic parameters and clinical and biochemical characteristics. Result(s) Risk factors for metabolic disease are associated with a low age of menarche, high levels of high-sensitivity C-reactive protein and liver enzymes, and low levels of sex hormone-binding globulin. Overweight/obese status, polycystic ovary syndrome, oligo/amenorrhea, and hyperandrogenism were found to increase the risk of cardiometabolic disease. However, hyperprolactinemia and premature ovarian failure were not associated with the risk of cardiometabolic disease. In terms of androgens, the serum total testosterone level and free androgen index but not androstenedione or dehydroepiandrosterone sulfate (DHEAS) were associated with cardiometabolic risk. Conclusion(s) Although polycystic ovary syndrome is associated with metabolic risk, obesity was the major determinant of cardiometabolic disturbances in reproductive-aged women. Hyperprolactinemia and premature ovarian failure were not associated with the risk of cardiovascular and metabolic diseases. Clinical Trial Registration Number NCT01826357.
AB - Objective To study the association between endocrine disturbances and metabolic complications in women seeking gynecologic care. Design Retrospective study, cluster analysis. Setting Outpatient clinic, university medical center. Patient(s) 573 women, including 384 at low risk and 189 at high risk of cardiometabolic disease. Intervention(s) None. Main Outcome Measure(s) Cardiovascular and metabolic parameters and clinical and biochemical characteristics. Result(s) Risk factors for metabolic disease are associated with a low age of menarche, high levels of high-sensitivity C-reactive protein and liver enzymes, and low levels of sex hormone-binding globulin. Overweight/obese status, polycystic ovary syndrome, oligo/amenorrhea, and hyperandrogenism were found to increase the risk of cardiometabolic disease. However, hyperprolactinemia and premature ovarian failure were not associated with the risk of cardiometabolic disease. In terms of androgens, the serum total testosterone level and free androgen index but not androstenedione or dehydroepiandrosterone sulfate (DHEAS) were associated with cardiometabolic risk. Conclusion(s) Although polycystic ovary syndrome is associated with metabolic risk, obesity was the major determinant of cardiometabolic disturbances in reproductive-aged women. Hyperprolactinemia and premature ovarian failure were not associated with the risk of cardiovascular and metabolic diseases. Clinical Trial Registration Number NCT01826357.
KW - Cardiovascular risk
KW - PCOS
KW - cluster analysis
KW - metabolic syndrome
UR - http://www.scopus.com/inward/record.url?scp=84899651621&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899651621&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2014.01.023
DO - 10.1016/j.fertnstert.2014.01.023
M3 - Article
C2 - 24534286
AN - SCOPUS:84899651621
SN - 0015-0282
VL - 101
SP - 1404-1410.e1
JO - Fertility and Sterility
JF - Fertility and Sterility
IS - 5
ER -